Implementing pharmacogenomics in europe: design and implementation strategy of the ubiquitous pharmacogenomics consortium

• In: Oral presentation on Wednesday, 13 September 2017, 09:00-12:00
• At: Seoul (South Korea) (2017)
• Type: Presentation
• By: HOLSAPPEL, Inge (Royal Dutch Pharmacists Association, Medicine Information Centre, Den Haag, Netherlands)
• Co-author(s): Inge Holsappel: Medicine Information Centre, Royal Dutch Pharmacists Association, Den Haag, Netherlands
  Ka-Chun Cheung: Medicine Information Centre, Royal Dutch Pharmacists Association, Den Haag, Netherlands
  Mandy Crommentuijn-van Rhenen: Medicine Information Centre, Royal Dutch Pharmacists Association, Den Haag, Netherlands
  Henk-Jan Guchelaar: Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands
  Christina Mitropoulou: The Golden Helix Foundation, London, United Kingdom
  Matthias Samwald: Center for Medical Statistics, Informatics, and Intelligent Systems, Medical University of Vienna, Vienna, Austria
  Matthias Schwab: Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology, Stuttgart, Germany;Clinical Pharmacology, University Hospital Tübingen, Tübingen, Germany;Pharmacy and Biochemistry, University of Tübingen, Tübingen, Germany
  Jesse Swen: Clinical Pharmacy & Toxicology, Leiden University Medical Center, Leiden, Netherlands
  
• Abstract:

  Methods

  On Jan 1^st2016 the consortium started with the preparations for the prospective, block-randomized, controlled clinical study (PREPARE). Among other things these preparations included inventarisation of existing guidelines and country-specific information, translation of guidelines in seven languages and selection of genetic variants for

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login